|
|
English
version
For å registrere i Cristin må du være vitenskapelig eller administrativt ansatt.
|
|
|
|
|
|
|
|
|
2021
|
1. |
Brenk, Ruth. Structure-based ligand design for protein and RNA targets for new antibiotics. CANS seminar series; 2021-03-26 UiB
Untitled
|
|
2. |
Brenk, Ruth. Structure-based ligand design for protein and RNA targets for new antibiotics. CANS seminar series; 2021-03-26 - 2021-03-26 UiB
Untitled
|
|
3. |
Brenk, Ruth. Structure-based ligand design for protein and RNA targets for new antibiotics. JPIAMR network TRANSLOCATION-transfer; 2021-05-04 - 2021-05-04 UiB
Untitled
|
|
4. |
Brenk, Ruth; Haug, Bengt Erik; Underhaug, Jarl; Georgiou, Charis. Targeting Bacterial Fatty Acid Synthesis using Fragment-Based Drug Design. BioCat Kick-off, Fall Semester 2021; 2021-09-02 - 2021-09-02 UiB
Untitled
|
|
5. |
Espeland, Ludvik Olai; Georgiou, Charis; Klein, Raphael; Bhukya, Hemalatha; Haug, Bengt Erik; Underhaug, Jarl; Mainkar, Prathama S.; Brenk, Ruth. An Experimental Toolbox for Structure-Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics. ChemMedChem 2021 ;Volum 16. s. 2715- UiB
Untitled
|
|
6. |
Lundquist, Kasper P.; Panchal, Vipul Navinchandra; Gotfredsen, Charlotte H.; Brenk, Ruth; Clausen, Mads H.. Fragment-Based Drug Discovery for RNA Targets. ChemMedChem 2021 UiB
Untitled
|
|
7. |
Panchal, Vipul Navinchandra; Brenk, Ruth. Riboswitches as Drug Targets for Antibiotics. Antibiotics 2021 ;Volum 10.(1) s. 1-22 UiB
Untitled
|
|
8. |
Rekand, Illimar Hugo; Brenk, Ruth. DrugPred_RNA—A Tool for Structure-Based Druggability Predictions for RNA Binding Sites. Journal of Chemical Information and Modeling 2021 ;Volum 61.(8) s. 4068-4081 UiB
Untitled
|
|
9. |
Sutton, Samuel. The Search for Antibiotic Leads: Targeting Pantothenate Kinase in Pseudomonas aeruginosa. : Institutt for biomedisin, Universitetet i Bergen 2021 UiB
Untitled
|
|
10. |
Yadrykhinsky, Vladyslav. Structure-based drug design of β-ketoacyl-[acyl carrier protein] synthase I (FabB) inhibitors as lead structures for new antibiotics. : Institutt for biomedisin, Universitetet i Bergen 2021 UiB
Untitled
|
|